McSAF is a Deeptech company specialized in Bio-Organic & Bio-Conjugates Chemistry, developing innovative technologies for improved targeted therapies.
Its core expertise covers Therapeutic Peptides and Proteins, Antibodies, and Drug Conjugates.
The team has a strong background in synthetic selective chemistry, and a real expertise in bioconjugation, including specific designs of Antibody Drug Conjugates (ADCs) with own proprietary coupling technology.
Plus, the company has now a pipeline of three products in oncology incorporating McSAF Inside technology with the ambition to bring new biodrugs on the market solving unmet medical needs.
Company Details
- Employees
- 6
- Founded
- -
- Phone
- +33(0) 2 47 25 00 26
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- mcsaf.fr
Mcsaf Questions
Mcsaf's helpline number is +33(0) 2 47 25 00 26
Mcsaf's website is mcsaf.fr
Mcsaf's LinkedIn profile is https://fr.linkedin.com/company/mcsaf
Mcsaf has
6 employees.
View email and phone details for 6
employees at Mcsaf.
Mcsaf's industry is
Pharmaceutical Manufacturing
Mcsaf's top competitors are
Hephaistos-Pharma,
Therasonic,
Elikya Therapeutics,
Genexpath,
Orakl Oncology,
Roche,
Qubit Pharmaceuticals,
Jalon Therapeutics,
Paris Saclay Cancer Cluster (Pscc),
Cure51.
Mcsaf's categories are Pharmaceutical Manufacturing
Mcsaf's founding year is 2015
